MLSS: Prakiraan rega marang bathi Milestone Scientific Corporation
Milestone Scientific (MLSS) is scaling B2B sales of DPS systems for dental practices, expanding its market share. The company's forward P/E ratio on the GURU.Markets chart shows that the parameter reaches 0.00. Shipments of Wand devices are generating current profit, although patent protection and physician conservatism are slowing the adoption of new technologies, creating significant barriers to entry.
Rincian analitis lan laporan data perusahaan Milestone Scientific Corporation (MLSS)
- nilai saham lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- statistik nilai buku emiten:
- indikator beban utang lan likuiditas:
Utang marang Ekuitas Milestone Scientific|MLSS - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Milestone Scientific|MLSS - Tanggungan utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Milestone Scientific Inc|MLSS - Silihan lan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Milestone Scientific|Likuiditas cepet milestonescientific.com
- statistik bathi lan rasio pasar:
MLSS - Penghasilan resik|Proyeksi bathi mangsa ngarep Milestone Scientific|MLSS - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Milestone Scientific Corp|MLSS - Rasio P/E diaturake wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Milestone Scientific Inc|MLSS - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Milestone Scientific|MLSS - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan milestonescientific.com|MLSS - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Milestone Scientific
Ringkesan analisis perusahaan:MLSS Milestone Scientific Inc.
The expansion of DPS systems into the dental sector directly impacts the expected profits of Milestone Scientific (MLSS), determining the asset's investment attractiveness. By analyzing the company's forward P/E ratio, calculated as the ratio of market price to projected EPS, an investor assesses the premium paid for future growth and the risks of capital overvaluation during a prolonged decline in market business valuations.
Pesaing langsung
Rega marang bathi mangsa ngarep Intuitive (ISRG)|Rega marang bathi mangsa ngarep DHR (Danaher Corporation)|Becton, Dickinson and Company - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi STE|West Pharmaceutical Services - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi baxter.com BAX|Masimo (MASI) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep STVN|Rega marang bathi mangsa ngarep Teleflex Inc|Merit Medical Corp (MMSI) - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi NVST (Envista Holdings)|Rasio kapitalisasi marang bathi mangsa ngarep ICUI|Rega marang bathi mangsa ngarep Dentsply Sirona XRAY|Pangali mangsa ngarep rega marang bathi LMAT|ATRC: Prakiraan rega marang bathi|STAA - Pangali Forward P/E|niagenbioscience.com (NAGE) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi zimvie.com|ANGO (AngioDynamics) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Cerus Corp. CERS|Rega marang bathi mangsa ngarep Alpha Teknova Inc (TKNO)|Monogram Orthopedics Inc. - Rasio rega marang bathi mangsa ngarep|Sharps Technology - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep INFU (InfuSystem)|UTMD - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi KORU Medical Systems KRMD|Nyxoah, S.A. (NYXH) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Microbot Medical, Inc|PDEX (Pro-Dex, Inc.) - Pangali Forward P/E|zentek.com (ZTEK) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Elutia (ELUT)|Rega marang bathi mangsa ngarep NXGL (NEXGEL Inc.)|Pangali Forward P/E RVP (Retractable Technologies, Inc.)|harvardbioscience.com (HBIO) - Rasio prakiraan rega marang bathi|FEMY - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi MeihuaMed MHUA|POAI (predictive-oncology.com) - Prakiraan rega marang bathi|CJMB: Rasio kapitalisasi marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Atrion Corp|Rasio prakiraan rega marang bathi NeuroMetrix Corporation NURO
